148 related articles for article (PubMed ID: 12776270)
1. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.
Makita Y; Moczulski DK; Bochenski J; Smiles AM; Warram JH; Krolewski AS
Am J Kidney Dis; 2003 Jun; 41(6):1189-94. PubMed ID: 12776270
[TBL] [Abstract][Full Text] [Related]
2. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
[TBL] [Abstract][Full Text] [Related]
3. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy.
Moczulski D; Fojcik H; Zukowska-Szczechowska E; Szydlowska I; Grzeszczak W
Nephrol Dial Transplant; 2003 Aug; 18(8):1535-40. PubMed ID: 12897091
[TBL] [Abstract][Full Text] [Related]
4. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.
Sun J; Xu Y; Zhu Y; Lu H
Diabetes Res Clin Pract; 2004 Jun; 64(3):185-90. PubMed ID: 15126006
[TBL] [Abstract][Full Text] [Related]
6. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
Sun J; Xu Y; Zhu Y
Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.
Zhou TB; Drummen GP; Jiang ZP; Li HY
Ren Fail; 2015; 37(8):1247-59. PubMed ID: 26161693
[TBL] [Abstract][Full Text] [Related]
8. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy.
Ukinc K; Ersoz HO; Karahan C; Erem C; Eminagaoglu S; Hacihasanoglu AB; Yilmaz M; Kocak M
Endocrine; 2009 Oct; 36(2):255-61. PubMed ID: 19598005
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
Lim PS; Hung WR; Wei YH
Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
[TBL] [Abstract][Full Text] [Related]
10. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
[TBL] [Abstract][Full Text] [Related]
11. The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients.
Tomić NG; Marusić S; Bozikov V; Kusec R; Bacić-Vrca V; Tadić M
Coll Antropol; 2013 Sep; 37(3):789-93. PubMed ID: 24308218
[TBL] [Abstract][Full Text] [Related]
12. Association between end-stage diabetic nephropathy and MTHFR (C677T and A1298C) gene polymorphisms.
Ramanathan G; Harichandana B; Kannan S; Elumalai R; Sfd P
Nephrology (Carlton); 2019 Feb; 24(2):155-159. PubMed ID: 29227003
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus.
Sun J; Xu Y; Zhu Y; Lu H
J Endocrinol Invest; 2006 Oct; 29(9):814-20. PubMed ID: 17114913
[TBL] [Abstract][Full Text] [Related]
14. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
15. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.
Khandanpour N; Willis G; Meyer FJ; Armon MP; Loke YK; Wright AJ; Finglas PM; Jennings BA
J Vasc Surg; 2009 Mar; 49(3):711-8. PubMed ID: 19157768
[TBL] [Abstract][Full Text] [Related]
16. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
17. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
18. Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications.
Movva S; Alluri RV; Venkatasubramanian S; Vedicherla B; Vattam KK; Ahuja YR; Hasan Q
Genet Test Mol Biomarkers; 2011 Apr; 15(4):257-61. PubMed ID: 21186995
[TBL] [Abstract][Full Text] [Related]
19. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
[TBL] [Abstract][Full Text] [Related]
20. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
